A5VM68 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigtmx4uy3k6x4lnqbmzskf4dnbjihi7bokejyvhrh4kldt7qdejrq/metadata.json
IPFS of structure file: 
bafybeieikzmei7g4u375dxs6oji7ewshqrolnusrzxycfprqltpnmjx46m/AF-A5VM68-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xFD0Ea450F76abf096AF1f75888221550A4d01857
First NFT owner address (bech32): 
genesis1l582g58hd2lsj6h37avgsgs42zjdqxzhqak2kz
Current NFT ID #166684 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166684
Accession (UniProt):
A5VM68
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
Limosilactobacillus reuteri (strain DSM 20016)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A5VM68 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A5VM68|HEM1_LIMRD Glutamyl-tRNA reductase OS=Limosilactobacillus reuteri (strain DSM 20016) OX=557436 GN=hemA PE=3 SV=1 MYLMCVSLNYHQLPLDLREKFSFTKEEVPKADKLLNDEKSILENLLISTCNRTEVYAVVDQIHTGRYYIRRFLAEWFHYTIDDFTKFVTVTTKDAVAEHLFKVITGLDSLIKGEPQILGQMKDAFQIATKEGTTGAILNHLFRQAITFSKRMHTKYRVSELAQSSGQAGLHQIKMQFGSLEGKTLAVVGLGQIGKHTAYNASNMGFSKVLLLNRTDSKAEQIATELQGVVEARPFNQLATVVHNVDAAIFAATVKQPLFKADEQISTMIVDLGVPRNVAVNSTKLKYYDVDHVHMILNSNDEKRRLMIQKIANEIPQEVNDFYIWEKQLHIVPVIRGLREHSLRIEGEAYDSLLRKLPELDSHERKVISKHMKSIVNQMIKGPIKEIKELSVTPGATADIDFFCKIFGMDNLKVENQNNDK